Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer

J Robot Surg. 2024 Feb 17;18(1):80. doi: 10.1007/s11701-024-01832-x.

Abstract

Early-stage cervical cancer (ESCC) is managed with radical hysterectomy, a procedure that can be performed either via open surgery or minimally invasive surgery (MIS), the latter of which is accomplished via traditional laparoscopy or robotic-assisted surgery. Previously, MIS was routinely incorporated into the management of ESCC due to the approach's reduced operative morbidity and truncated hospital stay duration, but more recent clinical evidence has since impugned the efficacy of MIS because of the reportedly inferior disease-free survival and overall survival outcomes compared to open surgery. However, additional studies have documented equivalent outcomes among the various surgical modalities, suggesting further exploration of clinical factors as we endeavor to conclusively determine the standard of care for patients diagnosed with ESCC.

Keywords: Early-stage cervix cancer; Open surgery; Outcomes; Robotic-assisted surgery; Survival.

Publication types

  • Review

MeSH terms

  • Cervix Uteri
  • Female
  • Humans
  • Hysterectomy / methods
  • Laparoscopy* / methods
  • Minimally Invasive Surgical Procedures / methods
  • Neoplasm Staging
  • Retrospective Studies
  • Robotic Surgical Procedures* / methods
  • Uterine Cervical Neoplasms* / pathology
  • Uterine Cervical Neoplasms* / surgery